IP Library Granted Patent US 9,089,720
Granted Patent B2
US 9,089,720 · App. 13/061,690 · Granted Jul 28, 2015

Hair growth promoting agent containing 15,15-difluoroprostaglandin F

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,089,720
App. No.
13/061,690
Granted
Jul 28, 2015
Kind
B2
Abstract

The present invention provides a new pharmaceutical application of a 15,15-difluoroprostaglandin F 2α derivative. As a result of intensive studies in order to find a new pharmaceutical application of a 15,15-difluoroprostaglandin F 2α derivative, it was found that, in a European Phase III clinical trial for tafluprost, one of the 15,15-difluoroprostaglandin F 2α derivatives, with patients with open-angle glaucoma or ocular hypertension, tafluprost has actions of growing eyelashes, making eyelashes thicker, and changing the color thereof, that is, has an effect of promoting the growth of hair (eyelashes). Therefore, a 15,15-difluoroprostaglandin F 2α derivative is useful as a hair growth promoting agent, and is expected to be useful as an active ingredient of a preventive or therapeutic agent for a disease associated with hair such as alopecia and a hair care product or a hair cosmetic product for regrowing hair, growing hair, increasing hair density, nourishing hair, or the like.

Claims (4)

1. A method for promoting the growth of eyelashes comprising administering to an eye of a patient in need thereof a pharmacologically effective amount of tafluprost or a pharmaceutically acceptable salt thereof.

2. A method for thickening eyelashes comprising administering to an eye of a patient in need thereof a pharmacologically effective amount of tafluprost or a pharmaceutically acceptable salt thereof.

3. A method for changing the color of eyelashes comprising administering to an eye of a patient in need thereof a pharmacologically effective amount of tafluprost or a pharmaceutically acceptable salt thereof.

4. A method of treating alopecia of the eyelashes comprising administering to an eye of a patient in need thereof a pharmaceutically effective amount of tafluprost or a pharmaceutically acceptable salt thereof.

Assignments (3)
CHANGE OF NAME Recorded Aug 7, 2018
From: ASAHI GLASS COMPANY, LIMITED
To: AGC INC.
Reel/Frame 046730/0786 →
CORPORATE ADDRESS CHANGE Recorded Nov 9, 2011
From: ASAHI GLASS COMPANY, LIMITED
To: ASAHI GLASS COMPANY, LIMITED
Reel/Frame 027197/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2011
From: ROPO, AULI
To: SANTEN PHARMACEUTICAL CO., LTD.; ASAHI GLASS COMPANY, LIMITED
Reel/Frame 025882/0905 →